Clinical Trial Update: The Prophylactic Use of Topical Cyclosporine A 0.05% to Prevent Graft Versus Host Disease Related Dry Eye [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated prophylactic topical cyclosporine A 0.05% to prevent graft-versus-host disease–related dry eye; the study sponsored by Massachusetts E…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• Cyclosporine A ophthalmic solution 0.05% (Cyclosporine A)

Snippet

Sponsor: Massachusetts Eye and Ear Infirmary | Conditions: Dry Eye | Phase 4 | Status: TERMINATED | Results posted: 2017-03-28